Drug Profile
Research programme: oral soluble film products - Aquestive Therapeutics/Strativa
Latest Information Update: 22 Jan 2018
Price :
$50
*
At a glance
- Originator MonoSol Rx
- Developer Aquestive Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in USA (Transmucosal, Film)
- 05 Jan 2010 Preclinical trials in Undefined indication in USA (Transmucosal)